SPOTLIGHT -
Top Five Pharma CEO Paypackets Total More Than $100M
June 8, 2015.
Sharp Rise in Emergency Contraceptive Sales in Germany
June 2, 2015.
UK Charity Criticizes NICE Cancer Drug Decision
June 1, 2015.
Turkey Emerges as "Global Hotspot for Healthcare"
May 20, 2015.
Endo Agrees to Buy Par Pharmaceutical for $8 Billion
May 18, 2015.
New Pharma Charity Initiative Targets Developing World
A range of packages is available for industry partners to implement charity giving.
EU Approves Novartis Lung Cancer Drug
Novartis announces that its lung cancer drug, Zykadia, gained European Union approval.
New Treatments Boost Global Hemophilia Market
May 7, 2015.
Asia-Pac Psoriasis Market to Double by 2021
EMA Tightens "Revolving Door" Rules for Members
May 6, 2015.
Global Spending on Cancer Drugs Hits $100 Billion
Alzheimer’s Disease Treatment Market to Exceed $13 Billion by 2023, says Report
Alexion Acquires Synageva for $8.4 Billion
Alexion announces it will expand its rare disease pipeline with a definitive agreement to acquire Synageva.
Biosimilar Giants Launch Forum
Eleven of the leading US biosimilar developers have collaborated to form the Biosimilars Forum, a nonprofit organization formed to expand patient access to biosimilars.
Quintiles Opens Bioanalytical Lab in Europe
May 5, 2015.
Prostate Cancer Market "to Treble to $8.2 Billion by 2023"
April 30, 2015.
Teva-Mylan-Perrigo Battles Continues with Another Rejection
Perrigo rejected Mylan’s second proposal for an acquisition valued at more than $34 billion, saying that the offer was too low to consider.
Takeda Offers $2.4 Billion to Settle Cancer Lawsuits
Takeda Pharmaceutical agrees to pay $2.4 billion to settle lawsuits from patients and family members who said the diabetes drug Actos caused bladder cancer.
FDA Releases Final Biosimilar Guidance
FDA releases long-awaited guidance documents regarding the assessment of biosimilarity.
FDA Fast Tracks Development of Sanofi Rare Disease Treatment
April 28, 2015.
The UK BioIndustry Association's Vision for the Sector in 2025
AZ Deal Fuels Innate Pharma Share Surge
April 27, 2015.
Pharma's $462 Billion of M&As Since Jan 2014
Newer Companies Shaking Up the Pharma Industry, Reports WSJ
April 24, 2015.
Teva Acquisition of Mylan "Could Transform Generics Space"
Advancements and Acquisitions Fueled Mid-Cap Biotech R&D Spend in 2014, Says Report
April 23, 2015.
Teva's $40 Billion Bid for Mylan
Teva announces that it would pay up to $40 billion in cash and stock to acquire Mylan.
Marketing Authorization More Likely for Companies Following EMA Clinical Development Plans
The European Medicines Agency releases findings from marketing authorization application analysis.
European Body Warns of "Antibiotic Armageddon"
April 21, 2015.
FDA Releases Draft Guidance on Promotional Labeling and Advertising
The agency has released draft guidance on providing regulatory submissions in regards to promotional labeling and advertising materials.